Medigene AG announced the expansion of the senior management team by appointing Dr. Dr. Olav Zilian as Senior Vice President Corporate Development, Dr. Kai Pinkernell as Senior Vice President/Chief Medical Officer (CMO) and Dr. Markus Dangl as Senior Vice President Research & Pre-Clinical Development.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 EUR | +0.37% | +11.52% | -11.15% |
21/05 | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
21/05 | Medigene AG's Global Research & Collaboration Agreement with BioNTech SE to Extend Beyond Initial Announced Term | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.15% | 4.28Cr | |
+18.72% | 12TCr | |
+14.53% | 11TCr | |
-2.88% | 2.47TCr | |
+4.89% | 2.27TCr | |
-9.79% | 1.81TCr | |
-41.04% | 1.67TCr | |
-11.83% | 1.66TCr | |
+1.46% | 1.35TCr | |
+24.22% | 1.13TCr |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- Medigene AG Announces Management Changes